Fate Therapeutics

Home    Contact Us
Skip to content
  • About Us
    • Management
    • Board of Directors
    • Founders
    • Investors
    • Vision, Mission & Values
    • Corporate Fact Sheet
  • Therapeutic Programs
    • ProHema
    • Muscle Regeneration
  • Science & Technology
    • Ex Vivo modulation
    • In Vivo modulation
    • iPSC
  • Partnerships
    • Becton Dickinson
  • Human Resources
    • Open Positions
  • News & Events
    • Press Releases
    • Publications
    • Awards
Home
to Transform the Lives of Patients with Rare Life-Threatening Disorders
Press Releases
Fate Therapeutics Presents Efficacy Data for WNT7a-Analog Program at Muscular Dystrophy Association 2013 Scientific Conference
April 22, 2013
 
Fate Therapeutics to Present at Cowen & Co. 33rd Annual Health Care Conference
February 25, 2013
 
Fate Therapeutics to Present at 15th Annual BIO CEO & Investor Conference
February 7, 2013
 
© 2013 Fate Therapeutics
|
Legal